Revenue
2011
2019
2020
Cocrystal Pharma, Inc. (COCP)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $2.0M | $6.6M | — | — | — | — | — | — | — | $12.7M | — |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | $7.2M | $2.7M | $6.8M |
| Research & development | $5.1M | $12.5M | $15.2M | $12.4M | $8.8M | $6.0M | $4.0M | $4.7M | $5.8M | $101.7M | $47.3M | $4.1M | $3.9M | $489,345 | $423,183 | $240,873 |
| Operating expenses | $9.0M | $17.9M | $18.6M | $38.8M | $14.2M | $11.6M | $55.0M | $62.9M | $8.3M | $105.8M | $54.0M | $5.8M | $4.1M | $2.6M | $6.6M | $6.9M |
| Operating income | −$9.0M | −$17.9M | −$18.6M | −$38.8M | −$14.2M | −$9.6M | −$48.4M | −$62.9M | −$8.3M | −$105.8M | −$53.9M | −$5.8M | −$4.1M | −$2.6M | −$3.9M | −$32,045 |
| EBITDAderived | −$8.9M | −$17.8M | −$18.4M | −$38.6M | −$14.0M | −$9.4M | −$48.3M | −$62.9M | −$8.2M | −$105.6M | −$53.8M | −$5.6M | −$3.8M | −$2.4M | −$3.4M | $400,521 |
| Net income | −$8.8M | −$17.5M | −$18.0M | −$38.8M | −$14.2M | −$9.6M | −$48.2M | −$49.0M | −$613,000 | −$74.9M | −$50.1M | −$99,000 | −$3.9M | −$8.0M | −$5.5M | −$319,813 |
| Basic EPSper diluted share | -$0.78 | -$1.72 | -$1.87 | -$4.77 | -$0.16 | -$0.17 | -$1.51 | -$1.75 | -$0.03 | -$3.18 | -$2.40 | $0.00 | -$0.07 | -$0.13 | -$0.11 | -$0.01 |
| Diluted EPSper diluted share | -$0.78 | -$1.72 | -$1.87 | -$4.77 | -$0.16 | -$0.17 | -$1.51 | -$1.75 | -$0.03 | -$3.30 | -$2.40 | -$0.01 | -$0.07 | — | -$0.11 | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 24, 2026Form 4 | FROST PHILLIP MD ET ALDirector,TenPercentOwner | BuyCommon Stock · indirect | 20.0K | $1.00 | $20.0K | 1.91M |
| Feb 6, 2026Form 4 | FROST PHILLIP MD ET ALDirector,TenPercentOwner | BuyCommon Stock · indirect | 50.0K | $0.95 | $47.5K | 1.89M |
| Dec 31, 2025Form 4 | FROST PHILLIP MD ET ALDirector,TenPercentOwner | BuyCommon Stock · indirect | 50.0K | $0.95 | $47.5K | 1.84M |
| Dec 30, 2025Form 4 | FROST PHILLIP MD ET ALDirector,TenPercentOwner | BuyCommon Stock · indirect | 20.0K | $0.97 | $19.4K | 1.79M |
| Dec 26, 2025Form 4 | FROST PHILLIP MD ET ALDirector,TenPercentOwner | BuyCommon Stock · indirect | 40.0K | $0.97 | $38.8K | 1.77M |